Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Cronos Group Inc.
  6. Summary
    CRON   CA22717L1013

CRONOS GROUP INC.

(CRON)
  Report
Delayed Toronto Stock Exchange  -  04:00 2022-06-30 pm EDT
3.600 CAD   -2.44%
06/28Cronos Group Partners with Geocann to Leverage VESIsorb Delivery Technology for Faster Absorption
AQ
06/27Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders
AQ
06/27Cronos Group Says to Use Geocann's VESIsorb Delivery Technology for Cannabinoid Products
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
06/24/2022 06/27/2022 06/28/2022 06/29/2022 06/30/2022 Date
4.03(c) 3.98(c) 3.91(c) 3.69(c) 3.6(c) Last
347 663 266 153 215 897 199 661 343 661 Volume
+4.68% -1.24% -1.76% -5.63% -2.44% Change
More quotes
Estimated financial data (e)
Sales 2022 150 M 116 M 116 M
Net income 2022 -134 M -104 M -104 M
Net cash position 2022 1 215 M 941 M 941 M
P/E ratio 2022 -10,8x
Yield 2022 -
Sales 2023 208 M 161 M 161 M
Net income 2023 -97,9 M -75,8 M -75,8 M
Net cash position 2023 1 180 M 913 M 913 M
P/E ratio 2023 -13,1x
Yield 2023 -
Capitalization 1 352 M 1 047 M 1 047 M
EV / Sales 2022 0,92x
EV / Sales 2023 0,83x
Nbr of Employees 626
Free-Float 52,1%
More Financials
Company
Cronos Group Inc. is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments... 
Read more
Sector
Pharmaceuticals
Calendar
08/11Earnings Release
More about the company
Ratings of Cronos Group Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about CRONOS GROUP INC.
06/28Cronos Group Partners with Geocann to Leverage VESIsorb Delivery Technology for Faster ..
AQ
06/27Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders
AQ
06/27Cronos Group Says to Use Geocann's VESIsorb Delivery Technology for Cannabinoid Product..
MT
06/27CRONOS GROUP BRIEF : Partners with Geocann to Leverage VESIsorb Delivery Technology for Fa..
MT
06/27Cronos Group Partners with Geocann to Leverage VESIsorb® Delivery Technology for Faster..
GL
06/27Cronos Group Partners with Geocann to Leverage VESIsorb® Delivery Technology for Faster..
GL
06/24CRONOS GROUP INC. : Submission of Matters to a Vote of Security Holders, Financial Stateme..
AQ
06/24Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders
GL
06/24Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders
AQ
06/24CRONOS : Announces Results of 2022 Annual Meeting of Shareholders - Form 8-K
PU
06/21Cronos Group and NYSE's Ginkgo Bioworks Announce Achievement of THCV Equity Milestone
MT
06/21CRONOS GROUP BRIEF : Says It and NYSE's Ginkgo Bioworks Announce Achievement of THCV Equit..
MT
06/21Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone
PR
06/21Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone
GL
06/15TSX gets boost from miners ahead of Fed decision
RE
More news
News in other languages on CRONOS GROUP INC.
06/14BOLSA DE MADRID : Los osos son liberados
06/14Les ours sont lâchés
05/27Aurora Cannabis augmente son financement par prise ferme ; baisse de 39,5 %.
05/10Cronos Group en hausse de 1,1 % avant le marché alors que sa perte du premier trimestre..
05/10Earnings Flash (CRON.TO) Le GROUPE CRONOS déclare une perte nette de 32,6523 millions d..
More news
Analyst Recommendations on CRONOS GROUP INC.
More recommendations
Analysis
Toronto index falls as energy stocks track weaker crude
Chart CRONOS GROUP INC.
Duration : Period :
Cronos Group Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRONOS GROUP INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 3,60 CAD
Average target price 6,21 CAD
Spread / Average Target 72,5%
EPS Revisions
Managers and Directors
Michael Ryan Gorenstein Chairman, President & Chief Executive Officer
Robert L. Madore Chief Financial Officer
Arye Weigensberg Vice President-Research & Technology
Jason Marc Adler Independent Director
James D. Rudyk Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CRONOS GROUP INC.-27.71%1 047
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.21.94%5 959
DONG-E-E-JIAO CO.,LTD.-25.44%3 493
TASLY PHARMACEUTICAL GROUP CO., LTD-33.94%2 322
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.-2.70%2 094
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK14.45%1 980